Lifecore Biomedical to Participate in Upcoming Investor Conferences

GlobeNewswire
09/03

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (「Lifecore」), a fully integrated contract development and manufacturing organization (「CDMO」), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows:

  • Morgan Stanley 23rd Annual Global Healthcare Conference
    Details: Lifecore management will participate in a fireside chat and in investor meetings
    Conference Dates: September 8-10, 2025
    Fireside Chat Time: 4:50 – 5:25 p.m. Eastern on Tuesday, September 9, 2025, webcast available
    Location: New York, NY
  • Barrington Research Virtual Fall Investment Conference
    Details: Lifecore management will participate in investor meetings
    Conference Date: September 16, 2025
    Location: Virtual
  • Jefferies CDMO Summit 2025
    Details: Lifecore management will participate in investor meetings
    Conference Date: September 17, 2025
    Location: London, UK

A live webcast of the Morgan Stanley fireside chat may be accessed via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

CONTACT: Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com 

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com 

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10